The price of this share is at 12,50$, In this post we are going to talk about the listed company POINT Biopharma Global Inc, its leaders are Jessica Jensen (Executive Vice President-Clinical Development), Joe McCann (Chief Executive Officer & Director), Neil E. Fleshner (Chief Medical Officer & Director), William Demers (Chief Financial Officer), they lead it to work in Specialty Chemicals especially in the North America region.
Yesterday this stock ended the day with a value of desconocido$.
With an intraday difference of 12,50$ moving between 12,49$ and 12,51$, it is a notable difference that allows quick purchases and sales.
Their latest annual data shows an income of desconocido.
The last value we have registered for the opening is desconocido.
One of the most interesting values to assess whether the price of a share is low or high is the minimum and maximum price of the last 52 weeks, in this case it has varied between 0,00$ and 0,00$.
EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].
Buscar
